Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 23

1.

Concomitant use of beta-blockers and beta2-agonists.

Ling Y, Saleem W, Shee CD.

Eur Respir J. 2008 Apr;31(4):905-6. doi: 10.1183/09031936.00153707. No abstract available.

2.

Beta-agonists, beta-blockers and obstructive airway disease.

Madalena Esteves M.

Eur Ann Allergy Clin Immunol. 2005 Dec;37(10):375-9. Review. No abstract available.

PMID:
16528900
3.

[Adrenergic beta agonists (adrenaline, dopamine, dobutamine, salbutamol); beta-blockers. Fundamentals and rules of use].

Lechat P.

Rev Prat. 1998 May 15;48(10):1115-21. Review. French. No abstract available.

PMID:
9781158
4.

Do partial agonist beta-blockers have improved clinical utility?

Fitzgerald JD.

Cardiovasc Drugs Ther. 1993 Jun;7(3):303-10. Review.

PMID:
8103354
5.

Beta-receptor-active agents: role of partial agonists in patients with heart failure.

Franciosa JA.

J Cardiovasc Pharmacol. 1989;14 Suppl 5:S44-7. Review.

PMID:
2478809
6.

Aspects of the pharmacology of beta-adrenoceptor agonists and antagonists.

Andersson KE.

Acta Anaesthesiol Scand Suppl. 1982;76:12-9. Review.

PMID:
6152879
7.

Beta-adrenergic therapy for glaucoma.

Polansky JR.

Int Ophthalmol Clin. 1990 Summer;30(3):219-29. Review. No abstract available.

PMID:
1974245
8.

[Heart failure: beta-stimulant or beta-blocker?].

Weber S, Cabanes L, Lanouar K, Degeorges M.

Rev Prat. 1988 Mar 17;38(9):542-9. Review. French. No abstract available.

PMID:
2895956
9.

Beta-adrenoceptor partial agonists: a renaissance in cardiovascular therapy?

Waller DG.

Br J Clin Pharmacol. 1990 Aug;30(2):157-71. Review. No abstract available.

10.

Heart failure and chronic obstructive pulmonary disease the quandary of Beta-blockers and Beta-agonists.

Hawkins NM, Petrie MC, Macdonald MR, Jhund PS, Fabbri LM, Wikstrand J, McMurray JJ.

J Am Coll Cardiol. 2011 May 24;57(21):2127-38. doi: 10.1016/j.jacc.2011.02.020. Review.

11.

Therapeutic implications of beta-adrenergic receptor pharmacodynamic properties.

Taira CA, Carranza A, Mayer M, Di Verniero C, Opezzo JA, Höcht C.

Curr Clin Pharmacol. 2008 Sep;3(3):174-84. Review.

PMID:
18781904
13.

[Clinical significance of changes in the number and function of adrenergic receptors].

Witkowska M.

Pol Arch Med Wewn. 1987 Apr;77(4):171-9. Review. Polish. No abstract available.

PMID:
2908417
14.
15.

Interactions between corticosteroids and beta2-agonists.

Hancox RJ.

Clin Rev Allergy Immunol. 2006 Oct-Dec;31(2-3):231-46. Review.

PMID:
17085796
16.

[Left ventricular diastolic dysfunction in ischemic heart disease. Effects of drug therapy].

Witkowska M.

Kardiol Pol. 1992 Dec;37(12):399-403. Review. Polish. No abstract available.

PMID:
1363437
17.

Getting to the heart of asthma: can "beta blockers" be useful to treat asthma?

Bond RA, Spina D, Parra S, Page CP.

Pharmacol Ther. 2007 Sep;115(3):360-74. Epub 2007 Jun 8. Review.

PMID:
17681610
18.

Adrenergic agonists and antagonists in the treatment of hypovolemic shock.

Williamson M.

J Am Med Womens Assoc. 1969 Dec;24(12):951-6 passim. Review. No abstract available.

PMID:
4391032
19.

Beta blockers: the extended family.

Hager WD, Messineo FC, Katz AM.

Adv Intern Med. 1984;30:201-29. Review.

PMID:
6152107
20.

Pharmacological criteria for the detection of beta 3-adrenoceptors.

De Ponti F.

Trends Pharmacol Sci. 1997 Feb;18(2):52-3. Review. No abstract available.

PMID:
9090310
Items per page

Supplemental Content

Write to the Help Desk